vorinostat has been researched along with Colitis, Granulomatous in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kwak, MS | 1 |
| Lee, HH | 1 |
| Cha, JM | 1 |
| Shin, HP | 1 |
| Jeon, JW | 1 |
| Yoon, JY | 1 |
| Buzza, MS | 1 |
| Johnson, TA | 1 |
| Conway, GD | 1 |
| Martin, EW | 1 |
| Mukhopadhyay, S | 1 |
| Shea-Donohue, T | 1 |
| Antalis, TM | 1 |
| Rosen, MJ | 1 |
| Frey, MR | 1 |
| Washington, MK | 1 |
| Chaturvedi, R | 1 |
| Kuhnhein, LA | 1 |
| Matta, P | 1 |
| Revetta, FL | 1 |
| Wilson, KT | 1 |
| Polk, DB | 1 |
3 other studies available for vorinostat and Colitis, Granulomatous
| Article | Year |
|---|---|
Novel candidate drugs in anti-tumor necrosis factor refractory Crohn's diseases: in silico study for drug repositioning.
Topics: Antibodies, Monoclonal; Computational Biology; Crohn Disease; Cyclosporins; Dioxolanes; Drug Discove | 2020 |
Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis.
Topics: Animals; Colitis, Ulcerative; Colon; Crohn Disease; Dextran Sulfate; Disease Models, Animal; Humans; | 2017 |
STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
Topics: Apoptosis; Blotting, Western; Case-Control Studies; Cells, Cultured; Child; Claudins; Colitis, Ulcer | 2011 |